Blastic plasmacytoid dendritic cell neoplasm and its treatment can have complications. The clinical course of this malignancy isÂ lethal without appropriate treatment. Despite treatment, relapses can happen. Therefore, close clinical monitoring and surveillance are recommended. The treatment for this malignancy can lead to pancytopenia, liver toxicity, renal dysfunction, capillary leak syndrome, and an increased risk of infections.

Capillary leak syndrome, characterized by low albumin, weight gain, edema, and hypotension, is a well-known and life-threatening complication of tagraxofusp.